|
⚲
|
| Keyboard |
| Flavin John L
✚
|
|
|---|---|
| CIK # | 0001126556 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001126556] | |
| 4 | [0001126556] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Flavin John L | |
| Pyxis Oncology Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2026-03-24 | Grant | 45,867 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Grant | 36,979 | $0.98 | 36,239 |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2024-03-26 | Grant | 35,219 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2023-03-24 | Grant | 139,355 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2022-03-31 | Grant | 66,831 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Series B Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 15,190 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2021-10-13 | Conversion | 2,388 | ||
|
Pyxis Oncology Inc PYXS
Stock Option (Right to buy) · derivative
|
2021-10-07 | Grant | 42,191 | $0.00 |